These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

767 related articles for article (PubMed ID: 7623530)

  • 61. Reteplase (Retavase).
    Med Lett Drugs Ther; 1997 Feb; 39(995):17-8. PubMed ID: 9057777
    [No Abstract]   [Full Text] [Related]  

  • 62. Thrombolytic treatment in acute myocardial infarction.
    Acar J; Vahanian A; Michel PL; Slama M; Cormier B; Roger V
    Semin Thromb Hemost; 1987 Apr; 13(2):186-200. PubMed ID: 2957791
    [No Abstract]   [Full Text] [Related]  

  • 63. Platelet function and fibrinolytic agents: two sides of a coin?
    Callahan KP; Malinin AI; Gurbel PA; Alexander JH; Granger CB; Serebruany VL
    Cardiology; 2001; 95(2):55-60. PubMed ID: 11423707
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The concept of equivalence and its application to the assessment of thrombolytic effects.
    Hampton JR
    Eur Heart J; 1997 Dec; 18 Suppl F():F22-7. PubMed ID: 9447337
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reteplase set to enter thrombolytic market.
    Am J Health Syst Pharm; 1997 Jan; 54(1):12. PubMed ID: 9117779
    [No Abstract]   [Full Text] [Related]  

  • 66. Effect of reteplase on hemostasis variables: analysis of fibrin specificity, relation to bleeding complications and coronary patency.
    Meierhenrich R; Carlsson J; Seifried E; Pfarr E; Smolarz A; Neuhaus KL; Tebbe U
    Int J Cardiol; 1998 Jun; 65(1):57-63. PubMed ID: 9699932
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.
    Lancet; 1992 Mar; 339(8796):753-70. PubMed ID: 1347801
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Streptokinase. A pharmacoeconomic appraisal of its use in the management of acute myocardial infarction.
    Gillis JC; Goa KL
    Pharmacoeconomics; 1996 Sep; 10(3):281-310. PubMed ID: 10163575
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.
    Donnan GA; Davis SM; Chambers BR; Gates PC; Hankey GJ; McNeil JJ; Rosen D; Stewart-Wynne EG; Tuck RR
    JAMA; 1996 Sep; 276(12):961-6. PubMed ID: 8805730
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group.
    Lancet; 1990 Jul; 336(8707):71-5. PubMed ID: 1975322
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators.
    Califf RM; Woodlief LH; Harrell FE; Lee KL; White HD; Guerci A; Barbash GI; Simes RJ; Weaver WD; Simoons ML; Topol EJ
    Am Heart J; 1997 Jun; 133(6):630-9. PubMed ID: 9200390
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.
    Crabbe SJ; Grimm AM; Hopkins LE
    Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Post-Reteplase Evaluation of Clinical Safety & Efficacy in Indian Patients (Precise-In Study).
    Singh RK; Trailokya A; Naik MM
    J Assoc Physicians India; 2015 Apr; 63(4):30, 32-5. PubMed ID: 26591167
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial.
    Kastrati A; Mehilli J; Schlotterbeck K; Dotzer F; Dirschinger J; Schmitt C; Nekolla SG; Seyfarth M; Martinoff S; Markwardt C; Clermont G; Gerbig HW; Leiss J; Schwaiger M; Schömig A;
    JAMA; 2004 Feb; 291(8):947-54. PubMed ID: 14982910
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intravenous NPA for the treatment of infarcting myocardium early; InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction.
    InTIME-II Investigators
    Eur Heart J; 2000 Dec; 21(24):2005-13. PubMed ID: 11102251
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Thrombolytics and myocardial infarction.
    Kunadian V; Gibson CM
    Cardiovasc Ther; 2012 Apr; 30(2):e81-8. PubMed ID: 21070617
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Benefical effects of reteplase in combination with abciximab: platelet/leukocyte interactions and coagulation system.
    Szabo S; Walter T; Etzel D; Ehlers R; Kazmaier S; Beyer ME; Hoffmeister HM
    Int J Clin Pharmacol Res; 2003; 23(2-3):37-40. PubMed ID: 15018016
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Thrombolytic therapy of acute myocardial infarction].
    Verstraete M
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1883-9. PubMed ID: 8729370
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy.
    Mahaffey KW; Granger CB; Collins R; O'Connor CM; Ohman EM; Bleich SD; Col JJ; Califf RM
    Am J Cardiol; 1996 Mar; 77(8):551-6. PubMed ID: 8610601
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pitfalls in the economic evaluation of thrombolysis in myocardial infarction. The impact of national differences in the cost of thrombolytics and of differences in the efficacy across patient subgroups.
    Lorenzoni R; Pagano D; Mazzotta G; Rosen SD; Fattore G; De Caterina R; Gensini G
    Eur Heart J; 1998 Oct; 19(10):1518-24. PubMed ID: 9820990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.